Cargando…

Effect of β-Blocker Therapy on the Level of Soluble ST2 Protein in Pediatric Dilated Cardiomyopathy

Background and Objectives: A prognosis for kids with pediatric dilated cardiomyopathy (PDCM) is urgently needed to identify high-risk patients. This study aimed to determine the association of levels and soluble suppression of tumorigenicity 2 (sST2) and medical therapy of β-blocker inhibitors with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Meng, Wang, Xiaofang, Liang, Yongmei, Yang, Yifei, Gu, Yan, Wang, Zhiyuan, Lv, Zhenyu, Jin, Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606944/ https://www.ncbi.nlm.nih.gov/pubmed/36295500 http://dx.doi.org/10.3390/medicina58101339

Ejemplares similares

Higher Serum Lysophosphatidic Acids Predict Left Ventricular Reverse Remodeling in Pediatric Dilated Cardiomyopathy
por: Wen, Haichu, et al.
Publicado: (2021)

Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies
por: Östman-Smith, Ingegerd
Publicado: (2014)

Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy
por: Reddy, Sushma, et al.
Publicado: (2015)

Beta‐Blocker Use Is Associated With Prevention of Left Ventricular Remodeling in Recovered Dilated Cardiomyopathy
por: Enzan, Nobuyuki, et al.
Publicado: (2021)

Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy
por: Matsumura, Yoshihisa, et al.
Publicado: (2015)

The complete reversal effect following angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers after the primary diagnosis of dilated cardiomyopathy
por: Liu, Tao, et al.
Publicado: (2023)

Genotype and Cardiac Outcomes in Pediatric Dilated Cardiomyopathy
por: Khan, Rabia S., et al.
Publicado: (2021)

Pathogenic Roles of Cardiac Fibroblasts in Pediatric Dilated Cardiomyopathy
por: Tsuru, Hirofumi, et al.
Publicado: (2023)

The Molecular Role of Immune Cells in Dilated Cardiomyopathy
por: Wang, Enping, et al.
Publicado: (2023)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Long-Term Outcomes and Prognosticators of Pediatric Primary Dilated Cardiomyopathy in an Asian Cohort
por: Wang, Po-Yuan, et al.
Publicado: (2021)

Genetic variations of β-MYH7 in hypertrophic cardiomyopathy and dilated cardiomyopathy
por: Tanjore, Reena, et al.
Publicado: (2010)

Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy
por: Slart, R. H. J. A., et al.
Publicado: (2010)

Takotsubo Cardiomyopathy and β-Blocker Poisoning: A Case Report
por: Popa-Fotea, Nicoleta-Monica, et al.
Publicado: (2022)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Circulating microRNA signature for the diagnosis of childhood dilated cardiomyopathy
por: Jiao, Meng, et al.
Publicado: (2018)

GDF‐15 is a better complimentary marker for risk stratification of arrhythmic death in non‐ischaemic, dilated cardiomyopathy than soluble ST2
por: Stojkovic, Stefan, et al.
Publicado: (2018)

Pediatric idiopathic dilated cardiomyopathy: A single center experience
por: Azhar, Ahmad S.
Publicado: (2013)

Diagnostic Yield of Whole Exome Sequencing in Pediatric Dilated Cardiomyopathy
por: Long, Pamela A., et al.
Publicado: (2017)

The appropriate dose of angiotensin‐converting‐enzyme inhibitors or angiotensin receptor blockers in patients with dilated cardiomyopathy. The higher, the better?
por: Ishida, Junichi, et al.
Publicado: (2015)

Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020)

Differential Expression Profiles and Functional Prediction of Circular RNAs in Pediatric Dilated Cardiomyopathy
por: Sun, Wei, et al.
Publicado: (2020)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Cardiomyopathy, familial dilated
por: Taylor, Matthew RG, et al.
Publicado: (2006)

Dilated cardiomyopathy in childhood
por: Franklin, OM, et al.
Publicado: (2000)

Immunoadsorption in dilated cardiomyopathy
por: Wakabayashi, Y, et al.
Publicado: (2009)

Apoptosis in Dilated Cardiomyopathy
por: Hong, Bum Kee, et al.
Publicado: (2000)

Impact of Angiotensin I Converting Enzyme Insertion/Deletion Polymorphisms on Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy Risk
por: Yang, Jianmin, et al.
Publicado: (2013)

Speckle tracking echocardiography in hypokinetic non‐dilated cardiomyopathy: comparison with dilated cardiomyopathy
por: Mombeini, Hoda, et al.
Publicado: (2020)

Pathogenic Variants Associated With Dilated Cardiomyopathy Predict Outcome in Pediatric Myocarditis
por: Seidel, Franziska, et al.
Publicado: (2021)

Dilated Cardiomyopathy in Pediatric Crohn’s Patient: Is It a Manifestation or Consequence of Therapy?
por: Busaleh, Fadi, et al.
Publicado: (2021)

Effects of stem cell therapy on dilated cardiomyopathy
por: Jiao, Rong, et al.
Publicado: (2014)

Feasibility of the Omaha system for the care of children with dilated cardiomyopathy
por: Zhang, Qin, et al.
Publicado: (2023)

Pyroptosis Patterns Are Involved in Immune Microenvironment Regulation of Dilated Cardiomyopathy
por: Wang, Kexin, et al.
Publicado: (2022)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

Role of Soluble ST2 Levels and Beta-Blockers Dosage on Cardiovascular Events of Patients with Unselected ST-Segment Elevation Myocardial Infarction
por: Huang, Wei-Ping, et al.
Publicado: (2018)

Rare Presentation of β-Thalassemia Intermedia With a Phenotype of Dilated Cardiomyopathy
por: Nakaya, Yuichiro, et al.
Publicado: (2023)

Extracellular vesicles do not contribute to higher circulating levels of soluble LRP1 in idiopathic dilated cardiomyopathy
por: Roura, Santiago, et al.
Publicado: (2017)

Pediatric Primary Dilated Cardiomyopathy Gene Testing and Variant Reclassification: Does It Matter?
por: Towbin, Jeffrey A.
Publicado: (2020)

Development of Cardiac Events and Functional Recovery Prediction Models for Pediatric Dilated Cardiomyopathy
por: Kim, Dong-Hee, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_asfm5dufeco8ltm0csa1p5o1dc